Table 5.
Amount of progression on the MMSE and CDR-SB at 1, 3, and 5 years after baseline by sex, APOE ε4 status, and Persistency Index (PI)
After 1 Year | After 3 Years | After 5 Years | |
---|---|---|---|
b (95% CI) | b (95% CI) | b (95% CI) | |
MMSE | |||
Male | |||
no ε4 allele | |||
PI=0 | −0.50 (−1.30, 0.30) | −2.20 (−4.28, −0.11) | −4.82 (−8.05, −1.58) |
PI=1 | −1.12 (−4.90, 2.66) | −3.59 (−10.89, 3.71) | −6.36 (−19.28, 6.55) |
1 or 2 ε4 alleles | |||
PI=0 | −0.96 (−1.88, −0.04) | −3.38 (−5.82, −0.95) | −6.50 (−10.41, −2.59) |
PI=1 | −1.36 (−3.71, 0.99) | −7.91 (−13.23, −2.59) | −19.55 (−28.87, −10.22) |
Female | |||
no ε4 allele | |||
PI=0 | −2.43 (−3.02, −1.84) | −6.99 (−8.49, −5.50) | −11.16 (−13.49, −8.83) |
PI=1 | −0.95 (−5.30, 3.40) | −7.69 (−15.66, 0.27) | −20.89 (−39.12, −2.65) |
1 or 2 ε4 alleles | |||
PI=0 | −1.44 (−2.12, −0.76) | −5.38 (−7.18, −3.58) | −10.72 (−13.66, −7.79) |
PI=1 | −1.03 (−2.55, 0.49) | −2.32 (−6.17, 1.52) | −2.58 (−9.11, 3.96) |
CDR-Sum | |||
Male | |||
no ε4 allele | |||
PI=0 | 0.40 (−0.29, 1.09) | 1.66 (−0.15, 3.47) | 3.54 (0.74, 6.33) |
PI=1 | 1.19 (−2.13, 4.51) | 0.90 (−5.42, 7.22) | −2.93 (−14.12, 8.27) |
1 or 2 ε4 alleles | |||
PI=0 | 1.10 (0.37, 1.84) | 3.38 (1.53, 5.23) | 5.74 (2.91, 8.57) |
PI=1 | 0.27 (−1.74, 2.28) | 6.04 (1.90, 10.18) | 18.79 (11.83, 25.75) |
Female | |||
no ε4 allele | |||
PI=0 | 1.68 (1.18, 2.18) | 5.05 (3.79, 6.31) | 8.46 (6.50, 10.41) |
PI=1 | −0.76 (−3.83, 2.31) | 0.76 (−5.82, 7.34) | 6.34 (−5.26, 17.93) |
1 or 2 ε4 alleles | |||
PI=0 | 0.77 (0.23, 1.32) | 3.44 (2.08, 4.80) | 7.60 (5.47, 9.74) |
PI=1 | 1.31 (0.10, 2.52) | 3.21 (0.25, 6.17) | 4.14 (−0.66, 8.95) |
Abbreviations: MMSE=Mini-mental state examination; CDR-Sum = Clinical Dementia Rating scale - Sum of boxscores; PI=Persistency Index